Nora Henrikson, PhD, MPH
"I believe that our members are the key to helping us know how to deliver the best care possible."
Nora Henrikson, PhD, MPH
Assistant Investigator, Kaiser Permanente Washington Health Research Institute
206-287-4675
Twitter: @norahenrikson
Biography
Nora Henrikson, PhD, MPH, conducts research that seeks to improve the lives of people with cancer and their families. Her current projects include interventions to mitigate cancer-related financial hardship and to improve communication with families about genetic risk. In addition, she leads KPWA’s participation in the Kaiser Permanente Evidence-Based Practice Center.
Dr. Henrikson joined Kaiser Permanente Washington Health Research Institute as a research associate in 2010.
RESEARCH INTERESTS AND EXPERIENCE
-
Behavioral Science
Social/behavioral quantitative and qualitative research; intervention design; systematic review and evidence synthesis; epidemiology; patient-provider communication
-
Cancer
Genetic testing for cancer risk, cancer-related financial hardship
-
Social Determinants of Health
Financial hardship
-
Public Health Genetics
Social, ethical, and policy implications of genomics and precision health
Recent publications
Henrikson NB, Skelly AC. Economic studies part I: basics and terms. Evid Based Spine Care J. 2012 Nov;3(4):7-11. doi: 10.1055/s-0032-1328137. PubMed
Henrikson NB, Davison BJ, Berry DL. Measuring decisional control preferences in men newly diagnosed with prostate cancer. J Psychosoc Oncol. 2011;29(6):606-18. PubMed
Grossman D, Fishman P, Beck A, Reid R, Ritzwoller D, Martin D, Henrikson N, Hubbard R, Scrol A. Quasi-experimental evaluation of a value-based health plan design among healthcare employees. Clin Med Res. 2011;9(3-4):173-4.
Standaert CJ, Friedly J, Erwin MW, Lee MJ, Rechtine G, Henrikson NB, Norvell DC. Comparative effectiveness of exercise, acupuncture, and spinal manipulation for low back pain. Spine. 2011;36(21 Suppl):S120-30. PubMed
Henrikson NB, Ellis WJ, Berry DL. "It's not like I can change my mind later": reversibility and decision timing in prostate cancer treatment decision-making. Patient Educ Couns. Nov;77(2):302-7. Epub 2009 Apr 21.
Henrikson NB, Bowen D, Burke W. Does genomic risk information motivate people to change their behavior? Genome Med. 2009 Apr 2;1(4):37.
James RD, Yu JH, Henrikson NB, Bowen DJ, Fullerton SM. Strategies and stakeholders: minority recruitment in cancer genetics research. Community Genet. 2008;11:241-49.
Henrikson NB, Harris JN, Bowen D. Predictors of recruitment method to a cancer genetics registry. Cancer Epidemiol Biomarkers Prev. 2007 Jul;16(7):1387-92.
Henrikson NB, Burke W, Veenstra DL. Ancillary risk information and pharmacogenetic tests: social and policy implications. Pharmacogenomics J. 2008 Apr;8(2):85-9. PubMed
Battuello K, Henrikson NB. Access to and disclosure of genetic information: rights, duties and liabilities. In: Battuello K, Kuslzer P, O’Connor S, editors. Genetic technologies and the law: cases and materials. Carolina Academic Press; 2006.
profile
Why does Nora Henrikson study patients’ cost of treatment?
Dr. Henrikson’s Annals of Internal Medicine study describes 3 kinds of cost concerns that can affect cancer care.
video
Discussing patients’ concerns about cost of care
Nora Henrikson discusses her latest research published in the Annals of Internal Medicine in May 2019. (Vimeo, 3:50)
KPWHRI IN THE MEDIA
Cost-of-care conversations: How can health care be more transparent?
Avalere podcast, Feb. 22, 2019
health services & economics
Community health workers can help make the difference for patients
Leah Tuzzio, MPH, and colleagues describe an underutilized role that can help primary care become truly patient-centered.
Land Acknowledgment
Our Seattle offices sit on the occupied land of the Duwamish and by the shared waters of the Coast Salish people, who have been here thousands of years and remain. Learn about practicing land acknowledgment.